Ethical and Analytic Challenges With Genomic Sequencing of Relapsed Hematologic Malignancies Following Allogeneic Hematopoietic Stem-Cell Transplantation Noninvasive prenatal testing (NIPT) is a ...
Non-invasive prenatal testing (NIPT) on pregnant women to detect the risk of a fetus having rare genetic abnormalities may often be wrong, according to recent reports. These tests, according to ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Non-invasive prenatal testing, or NIPT, now shapes critical ...
It’s critical that the test you choose is accurate, and because both brands are reliable, it all boils down to how fast you want your results.
Our team of maternal-fetal medicine specialists and prenatal genetic counselors have extensive training and experience in prenatal genetic testing. Providers throughout the Mountain West regularly ...
BioReference Laboratories Inc. in Elmwood Park acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche. The Harmony Prenatal Test, Ariosa’s non-invasive prenatal screening ...
Sickle cell anemia is a rare blood disorder passed down in families. Doctors can test for the trait that causes it before, during, or soon after birth. Sickle cell anemia (SCA) is an inherited blood ...
A new test developed by researchers from Columbia University in New York City may help pregnant women learn if their developing fetus is at increased risk of miscarriage. The test is called the ...
Read full article: SAPD releases video of ‘persons of interest’ in murder of Brewer Academy student Simon Cuevas III Get ready for some fabulous deals for when you're on the go, your beauty routine ...
A prenatal test taken by millions of pregnant women globally was developed by Chinese gene company BGI Group in collaboration with the Chinese military and is being used by the firm to collect genetic ...
A disturbing report from The New York Times on the unreliability of prenatal blood testing for genetic abnormalities should do more than make us wish that the testing companies were better regulated.